nach oben

Journal of Neuro-Oncology

Erschienen in:

01.03.2016 | Clinical Study

Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation

verfasst von: Sylvia Cheng, John-Paul Kilday, Normand Laperriere, Laura Janzen, James Drake, Eric Bouffet, Ute Bartels

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

CNS germinomas have an excellent prognosis with radiation therapy alone. However, in children, volume and dose of CNS radiation are associated with neurocognitive and neuroendocrine sequelae. Our objective was to determine long-term outcomes of our cohort who received chemotherapy and reduced radiation. This retrospective cohort study analyzed treatment and outcome of intracranial germinoma patients consecutively treated at Sick Kids, Toronto, Canada, from January 2000 to December 2013. 24 children (13 male, 11 female; median age 13.36 years) were identified. Median follow up was 61 months (range 1–144 months). Tumor location was suprasellar (n = 9), bifocal (8), pineal (6), and basal ganglia (1). Three children showed dissemination on imaging. 2/24 had only elevated serum human chorionic gonadotropin, 3/24 only elevated lumbar cerebrospinal fluid (CSF) hCG, and 2/24 had both elevated serum and lumbar CSF hCG. 23/24 children completed treatment and received multi-agent chemotherapy followed by either ventricular radiation (2340–2400 cGy) (n = 9), ventricular radiation + boost (1600 cGy) (n = 8), whole brain (2340 cGy) (n = 3), focal (4000 cGy) (n = 2) or craniospinal radiation (2340 cGy) (n = 1). Five-year progression free and overall survival was 96 and 100 % respectively. 8/24 patients with ventricular radiation ± boost (2340/4000 cGy) displayed stable full scale intelligence quotient over a mean interval of 3 years following radiation, but showed declined processing speed. In this limited experience, excellent 5-year overall survival rates were achieved with chemotherapy followed by reduced whole ventricular radiation even if ventricular radiation was delivered without boost.

Merchant TE, Rose SR, Bosley C, Wu S, Xiong X, Lustig RH (2011) Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol 29:4776–4780. doi:10.1200/JCO.2011.37.9453 PubMedCentralCrossRefPubMed

Chemaitilly W, Sklar CA (2010) Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer 17:R141–R159. doi:10.1677/ERC-10-0002 CrossRefPubMed

Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22:706–713. doi:10.1200/JCO.2004.05.186 CrossRefPubMed

Galloway TJ, Indelicato DJ, Amdur RJ, Swanson EL, Smith AA, Marcus RB Jr (2012) Second tumors in pediatric patients treated with radiotherapy to the central nervous system. Am J Clin Oncol 35:279–283. doi:10.1097/COC.0b013e318210f533 CrossRefPubMed

Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T (1997) Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86:446–455. doi:10.3171/jns.1997.86.3.0446 CrossRefPubMed

Kobayashi T, Kageyama N, Kida Y, Yoshida J, Shibuya N, Okamura K (1981) Unilateral germinomas involving the basal ganglia and thalamus. J Neurosurg 55:55–62CrossRefPubMed

Villani A, Bouffet E, Blaser S, Millar BA, Hawkins C, Bartels U (2008) Inherent diagnostic and treatment challenges in germinoma of the basal ganglia: a case report and review of the literature. J Neurooncol 88:309–314. doi:10.1007/s11060-008-9568-7 CrossRefPubMed

Finlay J, da Silva NS, Lavey R, Bouffet E, Kellie SJ, Shaw E, Saran F, Matsutani M (2008) The management of patients with primary central nervous system (CNS) germinoma: current controversies requiring resolution. Pediatr Blood Cancer 51:313–316CrossRefPubMed

Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL (1996) Chemotherapy without irradiation–a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The first international central nervous system germ cell tumor study. J Clin Oncol 14:2908–2915PubMed

10.

Afzal S, Wherrett D, Bartels U, Tabori U, Huang A, Stephens D, Bouffet E (2010) Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy. J Neurooncol 97:393–399. doi:10.1007/s11060-009-0033-z CrossRefPubMed

11.

Matsutani M (2012) Multi-institutional, prospective phase 2 study for primary intracranial germ cell tumors. Neuro-oncology 14(suppl 1):i49–i55CrossRef

12.

Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology 15:788–796. doi:10.1093/neuonc/not019 PubMedCentralCrossRefPubMed

13.

Kawabata Y, Takahashi JA, Arakawa Y, Shirahata M, Hashimoto N (2008) Long term outcomes in patients with intracranial germinomas: a single institution experience of irradiation with or without chemotherapy. J Neurooncol 88:161–167. doi:10.1007/s11060-008-9542-4 CrossRefPubMed

14.

Douglas JG, Rockhill JK, Olson JM, Ellenbogen RG, Geyer JR (2006) Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas. J Pediatr Hematol Oncol 28:36–39PubMed

15.

Phi JH, Kim SK, Lee J, Park CK, Kim IH, Ahn HS, Shin HY, Kim IO, Jung HW, Kim DG, Paek SH, Wang KC (2013) The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions or metastasis? J Neurosurg Pediatr 11:107–114. doi:10.3171/2012.10.PEDS11487 CrossRefPubMed

16.

Ono N, Kakegawa T, Zama A, Nakamura M, Inoue HK, Misumi S, Tamura M (1992) Suprasellar germinomas; relationship between tumour size and diabetes insipidus. Acta Neurochir (Wien) 114:26–32CrossRef

17.

Merchant TE, Sherwood SH, Mulhern RK, Rose SR, Thompson SJ, Sanford RA, Kun LE (2000) CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 46:1171–1176. doi:10.1016/S0360-3016(99)00375-2 CrossRefPubMed

18.

Baranzelli MC, Patte C, Bouffet E, Couanet D, Habrand JL, Portas M, Lejars O, Lutz P, Le Gall E, Kalifa C (1997) Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer 80:1792–1797CrossRefPubMed

19.

Tao Y, Lian D, Hui-juan Z, Hui P, Zi-meng J (2011) Value of brain magnetic resonance imaging and tumor markers in the diagnosis and treatment of intracranial germinoma in children. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33:111–115. doi:10.3881/j.issn.1000-503X.2011.02.002 PubMed

20.

Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M (2007) Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 48:285–291. doi:10.1002/pbc.20815 PubMedCentralCrossRefPubMed

21.

Villano JL, Propp JM, Porter KR, Stewart AK, Valyi-Nagy T, Li X, Engelhard HH, McCarthy BJ (2008) Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries. Neuro Oncol 10:121–130. doi:10.1215/15228517-2007-054 PubMedCentralCrossRefPubMed

22.

McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 14:1194–1200. doi:10.1093/neuonc/nos155 PubMedCentralCrossRefPubMed

23.

Keene D, Johnston D, Strother D, Fryer C, Carret AS, Crooks B, Eisenstat D, Moghrabi A, Wilson B, Brossard J, Mpofu C, Odame I, Zelcer S, Silva M, Samson Y, Hand J, Bouffet E, Canadian Pediatric Brain Tumor C (2007) Epidemiological survey of central nervous system germ cell tumors in Canadian children. J Neurooncol 82:289–295. doi:10.1007/s11060-006-9282-2 CrossRefPubMed

24.

Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, MacDonald SM (2013) Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr 163:1448–1453CrossRefPubMed

25.

Phi JH, Kim SK, Lee YA, Shin CH, Cheon JE, Kim IO, Yang SW, Wang KC (2013) Latency of intracranial germ cell tumors and diagnosis delay. Childs Nerv Syst 29:1871–1881. doi:10.1007/s00381-013-2164-y CrossRefPubMed

26.

Ramelli GP, von der Weid N, Stanga Z, Mullis PE, Buergi U (1998) Suprasellar germinomas in childhood and adolescence: diagnostic pitfalls. J Pediatr Endocrinol Metab 11:693–697CrossRefPubMed

27.

Crawford JR, Santi MR, Vezina G, Myseros JS, Keating RF, LaFond DA, Rood BR, MacDonald TJ, Packer RJ (2007) CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology 68:1668–1673. doi:10.1212/01.wnl.0000261908.36803.ac CrossRefPubMed

28.

Kato T, Sawamura Y, Tada M, Murata J, Abe H, Shirato H, Fujieda K (1998) Occult neurohypophyseal germinomas in patients presenting with central diabetes insipidus. Neurosurg Focus 5:e6CrossRefPubMed

29.

Lafay-Cousin L, Millar BA, Mabbott D, Spiegler B, Drake J, Bartels U, Huang A, Bouffet E (2006) Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 65:486–492CrossRefPubMed

30.

Wang Y, Zou L, Gao B (2010) Intracranial germinoma: clinical and MRI findings in 56 patients. Childs Nerv Syst 26:1773–1777. doi:10.1007/s00381-010-1247-2 CrossRefPubMed

31.

Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer 43:126–133CrossRefPubMed

32.

Sawamura Y, Shirato H, Ikeda J, Tada M, Ishii N, Kato T, Abe H, Fujieda K (1998) Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 88:66–72. doi:10.3171/jns.1998.88.1.0066 CrossRefPubMed

33.

Kitamura K, Shirato H, Sawamura Y, Suzuki K, Ikeda J, Miyasaka K (1999) Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma. Int J Radiat Oncol Biol Phys 43:783–788CrossRefPubMed

34.

Ogino H, Shibamoto Y, Takanaka T, Suzuki K, Ishihara S, Yamada T, Sugie C, Nomoto Y, Mimura M (2005) CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys 62:803–808. doi:10.1016/j.ijrobp.2004.10.026 CrossRefPubMed

35.

Shibamoto Y, Takahashi M, Sasai K (1997) Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int J Radiat Oncol Biol Phys 37:505–510CrossRefPubMed

36.

Fujimaki TMM (2005) The Japanese Pediatric Brain Tumor Study Group. HCG-producing germinoma: analysis of Japanese Pediatric Brain Tumor Study Group results [abstract]. Neuro-oncology 7:518

37.

Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, Habrand JL, Thiesse P, Cuilliere JC, Bernier V, Ben-Hassel M, Frappaz D, Baranzelli MC, Bouffet E (2010) Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro-oncology 12:1318–1325. doi:10.1093/neuonc/noq093 PubMedCentralPubMed

38.

Souweidane MM, Krieger MD, Weiner HL, Finlay JL (2010) Surgical management of primary central nervous system germ cell tumors: proceedings from the second international symposium on central nervous system germ cell tumors. J Neurosurg Pediatr 6:125–130. doi:10.3171/2010.5.PEDS09112 CrossRefPubMed

39.

Brada M, Rajan B (1990) Spinal seeding in cranial germinoma. Br J Cancer 61:339–340PubMedCentralCrossRefPubMed

40.

Rogers SJ, Mosleh-Shirazi MA, Saran FH (2005) Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol 6:509–519. doi:10.1016/S1470-2045(05)70245-X CrossRefPubMed

41.

O’Neil S, Ji L, Buranahirun C, Azoff J, Dhall G, Khatua S, Patel S, Panigrahy A, Borchert M, Sposto R, Finlay J (2011) Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation. Pediatr Blood Cancer 57:669–673. doi:10.1002/pbc.23146 CrossRefPubMed

42.

Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20–S27. doi:10.1016/j.ijrobp.2009.02.091 PubMedCentralCrossRefPubMed

43.

Moore BD 3rd (2005) Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 30:51–63CrossRefPubMed

44.

Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE (2004) Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399–408. doi:10.1016/S1470-2045(04)01507-4 CrossRefPubMed

45.

Steinlin M, Imfeld S, Zulauf P, Boltshauser E, Lovblad KO, Ridolfi Luthy A, Perrig W, Kaufmann F (2003) Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain 126:1998–2008. doi:10.1093/brain/awg195 CrossRefPubMed

46.

Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H (1998) Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 34:104–110CrossRefPubMed

47.

Mabbott DJ, Monsalves E, Spiegler BJ, Bartels U, Janzen L, Guger S, Laperriere N, Andrews N, Bouffet E (2011) Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood. Cancer 117:5402–5411. doi:10.1002/cncr.26127 CrossRefPubMed

48.

Sands SA, Kellie SJ, Davidow AL, Diez B, Villablanca J, Weiner HL, Pietanza MC, Balmaceda C, Finlay JL (2001) Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the first international CNS germ-cell tumor study. Neuro-oncology 3:174–183PubMedCentralPubMed

Titel: Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation
verfasst von: Sylvia Cheng
John-Paul Kilday
Normand Laperriere
Laura Janzen
James Drake
Eric Bouffet
Ute Bartels
Publikationsdatum: 01.03.2016
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 1/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-015-2029-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report

Immunomonitoring in glioma immunotherapy: current status and future perspectives

Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas

Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS)

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas